Turing Pharmaceuticals | search
Click here to view Turing Pharmaceuticals news from 60+ newspapers.
Bookmark or Share- Martin Shkreli-founded drug company files for bankruptcyVyera, formerly known as Turing Pharmaceuticals, has between $10 million and $50 million in assets and between $1 million and $10 million in liabilities, according to a Chapter 11 petition...
- Martin Shkreli, pharmaceutical chief who increased price of ... - PBSNation Mar 9, 2018 2:28 PM EDT. NEW YORK — Martin Shkreli, the smirking “Pharma Bro” vilified for jacking up the price of a lifesaving drug, was sentenced Friday to seven years in prison for ...
- 'Pharma Bro' Martin Shkreli is ordered to return $64M, barred from drug ...Shkreli was CEO of Turing Pharmaceuticals — later Vyera — when it jacked up the price of Daraprim from $13.50 to $750 per pill, after obtaining exclusive rights to the decades-old drug in 2015.
- U.S. judge orders 'Pharma Bro' Martin Shkreli to pay back $64M, bars ...Imprisoned ex-CEO raised price of life-saving drug from $13.50 to $750 US. Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc., arrives for ...
- Vyera Pharmaceuticals - WikipediaVyera Pharmaceuticals (formerly Turing Pharmaceuticals) is a pharmaceutical company incorporated in Zug, Switzerland, with offices in New York City. The company started to do business in the US as Vyera Pharmaceuticals in September 2017.
More
